Myriad Genetics Inc (MYGN)

$12.19 0.20 (1.61%)

17:30 EDT MYGN Stock Quote Delayed 30 Minutes

Volume:

Previous Close $12.19

Market Cap 852.16M

PE Ratio 6.32

EPS 1.93

Volume (Avg. Vol.) 453,500

Day's Range 12.09 - 12.54

52-Week Range 9.24 - 47.10

Dividend & Yield N/A (N/A)

MYGN Stock Predictions, Articles, and Myriad Genetics Inc News

From InvestorPlace
From the Web

8 Genomic Testing Stocks That Can Ease the Sting of Theranos

By James Brumley, InvestorPlace Feature Writer Mar 27, 2019

InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.

10 Healthcare Stocks to Stave Off the Market Flu

By Louis Navellier, Editor, Growth Investor Apr 6, 2018

One thing is certain, healthcare isn’t going away.

3 Big Stock Charts for Thursday: Myriad Genetics, Inc. (MYGN), Wal-Mart Stores Inc (WMT) and Nucor Corporation (NUE)

By Johnson Research Group Mar 2, 2017

The technical pictures for Walmart (WMT), Myriad Genetics (MYGN) and Nucor (NUE) are seeing transitions that suggest the technical bulls are starting to buy into these improving trends.

Biggest Movers in Manufacturing Stocks Now – PTLA DPRX SGYP BIOA

By Portfolio Grader Dec 26, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – PTLA BIOA CRME FLXN

By Portfolio Grader Dec 23, 2016

The following stocks were moving the Manufacturing sector today.

32 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 21, 2016

This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Compare Brokers

52 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").